Special Session on COVID-19

Coronaviruses continue to pose significant global public health challenges, with SARS-CoV-2 highlighting the importance of pandemic preparedness, surveillance, and rapid response. Although the acute phase of the COVID-19 pandemic has passed, ongoing viral evolution, emerging variants, long COVID, and zoonotic transmission remain critical areas of research. This track focuses on the latest advances in coronavirus biology, diagnostics, vaccines, antiviral therapies, genomic surveillance, public health strategies, and future pandemic preparedness, bringing together experts to share innovative research and lessons learned.

Market Analysis: The global COVID-19 diagnostics, vaccines, and therapeutics market continues to evolve, driven by ongoing surveillance programs, the development of next-generation vaccines and antiviral therapies, and increasing investments in pandemic preparedness. Advances in molecular diagnostics, genomic sequencing, artificial intelligence, and digital health technologies are strengthening outbreak detection and response. Continued government funding, international collaboration, and research into emerging coronavirus variants are expected to support innovation and ensure long-term preparedness for future coronavirus outbreaks.

ALSO READ Infectious Diseases and Global Health Viral Infections Bacterial Infections Fungal Infections Vector-borne Diseases Virology and HIVAIDS Immunology and Clinical Microbiology Antiviral Drug Resistance Catheter-Associated Urinary Tract Infection Emerging Infectious Diseases Hospital-Acquired Infections HAIs Maternal-Fetal Infections Next-Generation Antibiotics Pediatric Infectious Diseases Sepsis Diagnosis and Care Zoonotic Diseases Neurological and CNS Infections Healthcare-Associated Infections Ophthalmological Infectious Diseases Lower Respiratory and Pediatric IDs Genomics and Infectious disease Special Session on COVID-19 Vaccines and Immunizations Antibiotic Sensitivity Testing Blood-Borne Disease Contagious Disease Encephalitis Global Pandemic Preparedness Influenza Surveillance Systems Microbiome and Immunity Occupational Safety and Health OSH Point-of-Care Testing POCT Travel-Related Infections Tropical Diseases and Parasitic Diseases Sexually Transmitted Diseases and STIs Pathophysiology and Diagnosis Clinical Trials and Case Studies Influencing Factors of IDs Advanced Treatments and Technologies Oral and Maxillofacial Infections Prevention and Control Public Health and Epidemiology Artificial Intelligence in ID Climate Change and Infections Gastroenteritis HIV and Co-Infections Malaria Elimination Strategies Neglected Tropical Diseases NTDs One Health Approach Rapid Diagnostic Innovations Tuberculosis Drug Resistance

Tags
Vector-Borne Diseases Conferences Epidemiology Conferences Virology Conferences Infection Conferences 2026 Europe Contagious Diseases Conferences Parasitology Conferences Pathology Conferences Infectious Diseases Conferences Mycology Conferences Influenza Conferences Infection Control Conferences Entomology Conferences Bacteriology Conferences Microbiology Conferences Infection Conferences 2026 USA

+1 (506) 909-0537